Financial Results
H1 2020
Dr. Heinz-Jürgen Bertram (CEO), Olaf Klinger (CFO) - Holzminden, August 6, 2020
Agenda
Results H1 2020
-
- Business development H1 2020 (Heinz-JürgenBertram, CEO)
- Financials in detail (Olaf Klinger, CFO)
-
Outlook and long-term objectives (Heinz-JürgenBertram, CEO)
-
2
1 Business development H1 2020
Heinz-Jürgen Bertram, CEO
3
Financial Highlights H1 2020
Sustained highly profitable growth despite global Corona crisis
Sales | Business Free Cash Flow2 | |||||
€1.821bn | €190m | |||||
+ 7.6 % reported incl. ADF/IDF | + 37.3 % vs. last year | |||||
+ 3.4 % organic growth | ||||||
EBITDA margin | Net income3 | |||||
21.6% | €169m | |||||
EBITDA +11.9 %1 to €393m | ||||||
Earnings per share4 € 1.25 | ||||||
Net Debt / EBITDA(N) 5
2.2x
incl. provisions for pensions and similar obligations 3.0x
Corona pandemic
Strong measures in place
Fully operational globally.
Shift in portfolio towards nutrition, hygiene and care.
1 | H1 2019 normalized for transaction and integration costs ADF/IDF | 4 undiluted | 4 |
2 | Business Free Cash Flow = EBITDA(N) - Investments+/- changes inWorking Capital | 5 Annualized EBITDA(N) |
3 Attributable to shareholders of Symrise AG
Sales H1 2020
Solid sales performance despite challenging market environment
Symrise Group
In €m (sales growth in %)
1,692 | 1,821 |
+€ 106m ADF/IDF | |
+3.4 % organic growth | |
2019 | 2020 |
+7.6% |
Comments
+3.4% organic sales growth
Driven by Nutrition and
Scent & Care
-
+7.6 % sales growth in reporting currency Reflecting +€ 106m ADF/IDF contribution and headwinds from currencies
-
Overall strong growth
But demand driven shift in our sales portfolio
5
Sales by segment in H1 2020
Nutrition has been strongest growth driver
in €m/organic growth in % | +2.6% | |
712 | 711 | |
H1 2019 | H1 2020 | -0.1% reported |
Scent & Care
Strong demand in Consumer Fragrance and Oral Care. Fine Fragrances and Sun Protection affected by lockdowns and travel restrictions. Add. Menthol capacity sold
+0.6% | Flavor | ||
637 | 636 | Shift from Out-of-home to At-home | |
consumption leading to growth in Savory, | |||
but lower demand in Beverages and | |||
H1 2019 | H1 2020 | -0.2% reported | Confectionary |
+10.5% | |||
Nutrition | |||
343 | 474 | Continued double digit growth in Pet Food | |
driven by increased global demand. | |||
H1 2019 | H1 2020 | +38.1% reported | ADF/IDF above expectations |
6
Shift in portfolio due to Corona crisis
The resilience of our business is based on our wide range of applications
Certain application areas suffer from lockdowns and travel restrictions, other benefit from changed consumer habits. Due to our diversifies portfolio, we will continue to grow above market
Flavor
Flavor
Bev erages
Lower demand due to Corona lockdowns
Sweet
Slightly lower demand
Sav ory
High demand due to increased cooking at home
Nutrition
Diana | ADF/IDF | Probi* | |
Pet Food | Probiotics | ||
Continued high | Moderate | ||
demand, double | growth | ||
digit growth | momentum |
Food Increasing demand due to cooking at home
Aqua Moderate growth
ADF/IDF
Growth above plan
Scent & Care
Fragrance
Fine Fragrances
Decreasing demand due to Corona lockdowns
Consumer
Fragrances
Increased demand of care and hygiene products
Oral Care
Excellent double digit growth
Cosmetic
Ingredients
Activ e
Ingredients
Stable business environment
Sun Protection
Lower demand due to travel restrictions
Botanicals
Stable environment
Colors
Stable business environment
Aroma
Molecules
Fragrance
Ingredients
Lower demand due to less activities in FF
Menthol
Double digit growth due to additional capacities & high demand of hygiene products
* Symrise holds a majority stake in the Swedish company Probi AB | 7 |
2 Financials in detail
Olaf Klinger, CFO
8
Group H1 2020
Continued solid organic growth
Sales development | Comments | ||||
In €m | |||||
3.4% | 6.3% | -35.4 | 7.6% | Solid organic growth of 3.4% in H1 with 4.6% in Q2 driven | |
58.3 | 105.9 | -2.1% | by strong demand of Pet Food, Consumer Fragrance, Oral Care | ||
and Savory. | |||||
- | |||||
1,692.3 | 1,821.2 | Portfolio effect from ADF/IDF with sales of €106m. | |||
- | |||||
Negative currency effect of €35m mainly driven by weakening | |||||
of LATAM currencies. | |||||
H1 2019 | Organic | Portfolio | FX | H1 2020 | |
growth |
9
Group H1 2020
Profitability exceeding top-line growth
In €m | H1 2019 | H1 20191 | H1 2020 | Var. % | Comments | |||
normalized | ||||||||
Sales | 1,692.3 | 1,692.3 | 1,821.2 | 7.6 | ||||
Gross profit increase of 5,5 % mainly due to contribution of | ||||||||
Gross profit | 692.3 | 692.3 | 730.1 | 5.5 | ADF/IDF. Gross margin decrease from 40.9% to 40.1% due to | |||
proportional higher manufacturing costs from ADF/IDF. | ||||||||
EBITDA | 341.7 | 351.3 | 393.1 | 11.9 | - | |||
EBITDA increased by €42m to a 21.6% margin, reflecting | ||||||||
EBITDA margin in % | 20.2 | 20.8 | 21.6 | also lower operational expenses. | ||||
- | ||||||||
Depreciation | 59.4 | 59.4 | 67.6 | 13.8 | Higher D&A driven by last years investments and first-time | |||
consolidation of ADF/IDF. D&A impact of € 9m for ADF/IDF after | ||||||||
Amortization | 50.7 | 50.7 | 59.7 | 17.7 | preliminary finalization of PPA. | |||
- | ||||||||
EBIT | 231.6 | 241.2 | 265.8 | 10.2 | EBIT increase of €25m (+10%) underlines the profitable | |||
growth. | ||||||||
EBIT margin in % | 13.7 | 14.3 | 14.6 | |||||
1 Adjusted for transaction and integration costs related to business combinations | 10 |
Scent & Care H1 2020
Stable sales with shift in demand towards Consumer Fragrances
Sales development | Short P&L | ||||||
In €m | In €m | ||||||
H1 2019 | H1 2020 | Var. % | |||||
-19.0 | EBITDA | 140.2 | 146.1 | 4.2 | |||
2.6% | -0.1% | EBITDA margin | 19.7% | 20.6% | |||
18.2 | -2.7% | EBIT | 104.3 | 106.9 | 2.4 | ||
EBIT margin | 14.7% | 15.0% | |||||
711.7 | 710.9 | Comments | |||
Dynamic business momentum in Consumer Fragrances and Oral | |||||
Care with double-digit growth, Fine Fragrances and Cosmetic | |||||
Ingredients affected by lockdowns and travel restrictions. | |||||
H1 2019 | Organic | Portfolio | FX | H1 2020 | Aroma Molecules slightly below PY after high comparable, but strong |
menthol sales after capacity expansion. |
growth | - |
EBITDA up to 20.6 % mainly due to strict control of operating expenses. |
11
Flavor H1 2020
Portfolio shift towards products for increased at-homeconsumption
Sales development | Short P&L | ||||||||||||
In €m | In €m | ||||||||||||
H1 2019 | H1 2020 | Var. % | |||||||||||
0.6% | -4.9 | -0.2% | EBITDA | 144.3 | 147.5 | 2.2 | |||||||
EBITDA margin | 22.6% | 23.2% | |||||||||||
3.9 | -0.8% | ||||||||||||
EBIT | 115.6 | 117.2 | 1.4 | ||||||||||
EBIT margin | 18.1% | 18.4% | |||||||||||
637.4 | 636.4 | Comments | |||||||||||
Reduced demand in Beverages and Confectionary partly offset by | |||||||||||||
increased sales for savory, bakery products and cereals. | |||||||||||||
- | |||||||||||||
H1 2019 Organic Portfolio | FX | H1 2020 | EAME and Northern America on last years level; South East Asia | ||||||||||
growth | and China back on growth path. | ||||||||||||
- |
EBITDA increased to 23.2 % due strict cost discipline.
12
Nutrition H1 2020
Ongoing strong dynamics in Pet Food
Sales development | Short P&L | |||||||||||||
In €m | In €m | |||||||||||||
H1 2019 | H1 20191 | H1 2020 | Var. % | |||||||||||
30.9% | -11.5 | 38.1% | EBITDA | 57.2 | 66.8 | 99.6 | 49.1 | |||||||
EBITDA margin | 16.7% | 19.5% | 21.0% | |||||||||||
10.5% | -3.4% | |||||||||||||
EBIT | 11.6 | 21.3 | 41.7 | 96.0 | ||||||||||
36.2 | 105.9 | EBIT margin | 3.4% | 6.2% | 8.8% | |||||||||
473.9 | Comments | |||||||||||||
343.3 | ||||||||||||||
Very strong performance from Pet Food with double-digit growth in all | ||||||||||||||
regions; Food with good development in Asia/Pacific. | ||||||||||||||
- | ||||||||||||||
H1 2019 | Organic | Portfolio | FX | H1 2020 | Integration and sales of ADF/IDF above expectations. | |||||||||
growth | - | |||||||||||||
Profitability increased by 150 bps. | ||||||||||||||
1 Adjusted for transaction and integration costs related to business combinations | 13 |
Earnings Per Share H1 2020
New record high of €1.25
In €m | H1 2019 | H1 2019 | H1 2020 | Var. % | Comments | |||
normalized1 | ||||||||
EBIT | 231.6 | 241.2 | 265.8 | 10.2 | Financial result stable, despite high volatility of key currencies | |||
and ADF/IDF acquisition. | ||||||||
Financial result | -27.8 | -27.3 | -29.0 | 6.1 | - | |||
Stable income tax rate at 27.0%. | ||||||||
EBT | 203.8 | 213.9 | 236.9 | 10.7 | - | |||
EPS2 at new record level of €1.25 mainly as a result of increased | ||||||||
operating profit . | ||||||||
-55.1 | -64.0 | |||||||
Income tax | -57.9 | 16.2 | - | |||||
(27.0%) | (27.0%) | In July, additional Eurobond of € 500m until 2027 was | ||||||
Net income2 | 146.0 | 153.4 | 169.2 | 10.3 | successfully placed in the market to refinance existing debts due in | |||
Q4 2020. | ||||||||
EPS3 in € | 1.09 | 1.14 | 1.25 | 9.6 | ||||
1 Adjusted for transaction and integration costs; including IFRS 16 effect | 2Attributable to shareholders of Symrise AG | 14 |
3Undiluted
Business Free Cash Flow (BFCF)
Continued strong cash delivery
BFCF as % of Sales | 14.1% | ||||||||||
11.7% | |||||||||||
10.2% | 9.9% | 9.9% | 10.5% | ||||||||
9.9% | 7.3% | 7.8% | |||||||||
2016 | 2017 | 2018 | 2019 | 2020 | |||||||
Definition of BFCF: | H1 | FY | |||||||||
EBITDA | |||||||||||
minus | CAPEX | ||||||||||
minus/plus | Change in Working Capital | ||||||||||
= | Business Free Cash Flow | ||||||||||
BFCF H1 20201 increased by 37% to €190m
= 10.5% of sales
Strong EBITDA growth
Working Capital increase below topline
growth
CAPEX 3.1% of sales (€57m) after
4.6% (€78m) in H1 2019 with different phasing
Ambition 2020
BFCF around 14% of sales
1 Including IFRS 16 effect | 15 |
Balance Sheet
Solid financial position with equity ratio of 41.2 %
Assets | Equity and Liabilities | Comments | |||||||||||||||||
In €m | In €m | ||||||||||||||||||
5,953 | 5,885 | 5,953 | 5,885 | Reduced cash position due to paid dividend | |||||||||||||||
Cash & equiv. | 446 | 361 | 333 | 324 | Trade payables | in Q2 and payback of current financial | |||||||||||||
Trade receivables | 648 | 699 | liabilities. | ||||||||||||||||
- | |||||||||||||||||||
Borrowings | |||||||||||||||||||
Inventories | 892 | 924 | 1,966 | 1,905 | Trade receivables and Inventories | ||||||||||||||
increased due to current business environment | |||||||||||||||||||
Pensions | - | ||||||||||||||||||
605 | 616 | Borrowings: Decrease by €61m mainly due to | |||||||||||||||||
425 | 454 | Other | reduction of short-term debts. | ||||||||||||||||
Intangibles | 3,632 | 3,544 | 167 | 160 | Deferred tax | - | |||||||||||||
& PPE | liabilities | Pension provisions largely unchanged - | |||||||||||||||||
2,457 | 2,426 | Equity | German interest rates stable at 1.2%. | ||||||||||||||||
- | |||||||||||||||||||
Purchase Price Allocation for ADF/IDF | |||||||||||||||||||
Other | 335 | 357 | was in Q2 2020 preliminary. | ||||||||||||||||
FY 20199 1 | H1 2020 | FY 20199 1 | H1 2020 | ||||||||||||||||
1FY 2019 restated for finalized ADF/IDF based on preliminary Purchase Price Allocation | 16 |
Net Debt Development
Covenant in long-term target range
Net debt / EBITDA(N)1
Pinova | ADF/IDF + | |
capital increase | ||
acquisition & sale | ||
3,5 | ||
Diana + capital | ||
3,0 | increase | |
2,5
2,0
1,5
1,0
2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
H1 | ||||||||||||
Net debt (incl. provisions for pension and | Net debt/EBITDA(N) ratio | |||||||||||
similar obligations) /EBITDA(N) ratio |
Status Quo
- Net debt² of €1,645m reflects
2.2 x EBITDA(N)
-
Net debt² including pensions and similar obligation of € 2,261m reflects
3.0 x EBITDA(N)
Ambition
-
Long-termtarget of 2.0 to
2.5 x EBITDA (incl. pensions) - Unchanged since IPO
- Top priority: Remain an investment grade profile
1 2019 adjusted for transaction and integration costs related to business combinations | 17 |
2 Incl. lease obligations |
3 Outlook and long-term objectives
Heinz-Jürgen Bertram
18
Updated outlook 2020
Increased profitability target with an EBITDA margin of 21-22 %
Targets 2020 | Impact of Corona crisis well managed | |
Outperform growth of the relevant market
Grow th
3-4%
Organic growth
€m
3,408 | |
2019 | 2020 |
Symrise has put measures in place at all locations to |
provide employees and partners with optimal protection |
against the virus. |
We continue to be fully operational and are making every |
effort to supply our customers with the usual reliability. |
The crisis underscores the resilience and balance of our |
Profitability | Business Free |
EBITDA margin | Cash Flow (% of sales) |
21-22% | 14% |
~ |
business model. |
With our broad range of product solutions for food and |
beverages, personal care and hygiene, we serve the needs of |
everyday life, specially in these times the needs of everyday |
life. |
19
Objectives 2025
supported by our proven strategy
Financial goals | until | 2020 | until | 2025 | ||
Sales growth | 5 - 7 | % pa (CAGR) | 5 - 7 % pa (CAGR) | |||
Sales in Emerging Markets | > 50 | % | > 50 % | |||
Customer mix | 1/3 global, regional, local | 1/3 global, regional, local | ||||
EBITDA margin | 19 - 22 % | 20 - 23 % due to more favorable portfolio mix | ||||
CAPEX | 5 - 6 % | 4 - 5 % by 2022 most of the major invests completed | ||||
Dividend | 30 - 50 % | 30 - 50 % planned to be continued | ||||
Sustainability goal | ||||||
Environment | 33 % | improvement of footprint | 50 %* improvement of footprint | |||
*Science-based target (SBT) 2016-2025 | 20 |
Symrise AG
Financial Calendar 2020 | Contacts | |
29 October | Symrise AG | |
9M 2020 trading statement | Mühlenfeldstraße 1 | |
37603 Holzminden, Germany | ||
Tobias Erfurth | ||
Investor Relations | ||
tobias.erfurth@symrise.com | ||
Bernhard Kott | ||
Corporate Communications and Sustainability | ||
bernhard.kott@symrise.com | ||
This document contains forward-looking statements, which are based on the current estimates and assumptions by the corporate man agement of Symrise AG. Future performance and the results actually achieved by Symrise AG and its affiliated companies depend on a number of risks and unce rtainties and may therefore differ materially from the forward-looking statements. Many of these factors are outside Symrise's control and cannot be accurately estimated in advance, such as the future economic environment and the actions of competitors and others involved in the marketplace. Symrise neither plans nor undertakes to up date any forward-looking statements.
21
Attachments
- Original document
- Permalink
Disclaimer
Symrise AG published this content on 06 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 August 2020 07:48:13 UTC